IPONew ListingsGMPFIS ResearchIPO Analysis

Current IPO Watch: Symbiotec Pharmalab, Hy-Tech Engineers & Skyways Air Services — FIS View

Profile picture of FINANCIAL  INDEPENDENCE SERVICES
FINANCIAL INDEPENDENCE SERVICES · INH00002105824 Aug 2026 · 2 min read · Updated 24 Aug 2026, 12:18 pm
Current IPO Watch: Symbiotec Pharmalab, Hy-Tech Engineers & Skyways Air Services — FIS View

Three mainboard IPOs — Symbiotec Pharmalab, Hy-Tech Engineers and Skyways Air Services — are currently open for subscription from 24 August to 27 August 2026. Grey-market activity is showing positive sentiment across all three issues, although subscription levels and GMP differ considerably.

Symbiotec Pharmalab IPO

  • Price Band: ₹938–₹988
  • Lot Size: 15 shares
  • Issue Size: ₹1,757 crore
  • Current Subscription: 0.26 times
  • Current GMP: ₹370–₹390, approximately 37%

Symbiotec Pharmalab is currently showing strong grey-market interest. Based purely on the prevailing GMP, the issue is indicating healthy listing sentiment; however, current subscription levels remain relatively modest and should be monitored as the issue progresses.

Hy-Tech Engineers IPO

  • Price Band: ₹50–₹53
  • Lot Size: 283 shares
  • Issue Size: ₹135.73 crore
  • Current Subscription: 2.45 times
  • Current GMP: ₹20–₹21, approximately 38%

Among the three IPOs, Hy-Tech Engineers currently has the strongest combination of GMP and subscription momentum. Its approximately 38% grey-market premium indicates strong listing interest at present, while subscription demand is also comparatively better.

Skyways Air Services IPO

  • Price Band: ₹131–₹138
  • Lot Size: 100 shares
  • Issue Size: ₹582.8 crore
  • Current Subscription: 0.40 times
  • Current GMP: ₹23–₹25, approximately 17%

Skyways Air Services is also trading at a positive grey-market premium, although its current GMP is considerably lower than Symbiotec Pharmalab and Hy-Tech Engineers. Subscription levels should be tracked closely during the remaining IPO period.

FIS View

Based on the current GMP and subscription trends, Hy-Tech Engineers (~38%) and Symbiotec Pharmalab (~37%) are presently showing the strongest listing sentiment, while Skyways Air Services (~17%) remains in a positive but comparatively moderate GMP zone. Investors should remain selective and evaluate company fundamentals, valuations, final subscription data and broader market conditions along with GMP before applying.

Disclaimer: Grey Market Premium is unofficial, can change rapidly and is not a guarantee of listing gains or future performance. Investors should evaluate their own objectives and risk profile before making an investment decision.

Financial Independence Services
SEBI Registered Research Analyst — INH000021058